Solifenacin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Kidney & Urinary Care treatment.
🧴 Clinical Application
Take orally once daily, starting at 5 mg and titrating to 10 mg if needed, with liquids. Swallow the tablet whole; can be taken with or without food. Do not chew or crush. In severe renal impairment (CrCl < 30 mL/min) or moderate hepatic impairment, maximum dose is 5 mg daily.
⚠️ Side Effects
Common: Dry mouth (xerostomia), constipation, blurred vision, dyspepsia, nausea, dry eyes. Rare/Severe: Acute urinary retention, QTc prolongation, angioedema, and paralytic ileus.
🛡️ Safety Warnings
Contraindicated in urinary retention, severe gastrointestinal conditions (toxic megacolon), myasthenia gravis, and uncontrolled narrow-angle glaucoma. Monitor for heat exhaustion during hot weather due to decreased sweating.
Jan Aushadhi Products containing Solifenacin
Found 2 generic formulation(s) containing this active ingredient.
Solifenacin Succinate Tablets 5 mg
Solifenacin Succinate Tablets (5mg, 10mg) is a competitive, selective muscarinic M3 receptor antagonist on the WHO Model List framework for Overactive Bladder. It exhibits higher affinity for muscarinic M3 receptors over M1 and M2 subtypes, specifically blocking parasympathetic acetylcholine transmission in the bladder detrusor muscle to suppress involuntary detrusor contractions and increase bladder compliance and volume to first micturition. Indicated for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in Overactive Bladder syndrome.
Solifenacin Succinate Tablets 10 mg
Solifenacin Succinate Tablets (5mg, 10mg) is a competitive, selective muscarinic M3 receptor antagonist on the WHO Model List framework for Overactive Bladder. It exhibits higher affinity for muscarinic M3 receptors over M1 and M2 subtypes, specifically blocking parasympathetic acetylcholine transmission in the bladder detrusor muscle to suppress involuntary detrusor contractions and increase bladder compliance and volume to first micturition. Indicated for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency in Overactive Bladder syndrome.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Solifenacin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Solifenacin Succinate Tablets 5 mg | 10's | ₹60.94 | SOLITEN, SOLINOL, SOLICEPT, BISPEC, FLOSLO | ₹405.13 | 85% Save |
| Solifenacin Succinate Tablets 10 mg | 10's | ₹75.00 | SOLITEN | ₹484.84 | 85% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Solifenacin generics.